BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10853876)

  • 1. Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.
    Wacke R; Rohde B; Engel G; Kundt G; Hehl EM; Bast R; Seiter H; Drewelow B
    Eur J Clin Pharmacol; 2000 Apr; 56(1):43-8. PubMed ID: 10853876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
    Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
    Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.
    Primmett DR; Levine M; Kovarik JM; Mueller EA; Keown PA
    Ther Drug Monit; 1998 Jun; 20(3):276-83. PubMed ID: 9631924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
    Srinivas NR
    Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
    Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
    J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A absorption profiles in children with nephrotic syndrome.
    Nozu K; Iijima K; Sakaeda T; Okumura K; Nakanishi K; Yoshikawa N; Honda M; Ikeda M; Matsuo M
    Pediatr Nephrol; 2005 Jul; 20(7):910-3. PubMed ID: 15856324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies of cyclosporine monitoring in heart transplantation: initial results.
    Arizón del Prado JM; Aumente Rubio MD; Cárdenas Aranzana M; López Malo de Molina MD; Segura Saint-Gerons J; López Granados A; Rodríguez Esteban E; Ruiz Ortiz M; Romo Peñas E; Muñoz Carvajal I; González Rodríguez JR; Segura Saint-Gerons C; Vallés Belsué F; Concha Ruiz M
    Transplant Proc; 2003 Aug; 35(5):1984-7. PubMed ID: 12962870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
    Ragette R; Kamler M; Weinreich G; Teschler H; Jakob H
    J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients.
    Balram C; Sivathasan C; Cheung YB; Tan SB; Tan YS
    J Heart Lung Transplant; 2002 Sep; 21(9):1016-21. PubMed ID: 12231373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.
    Molpeceres J; Chacón M; Guzmán M; Berges L; del Rosario Aberturas M
    Int J Pharm; 1999 Sep; 187(1):101-13. PubMed ID: 10502617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predictive model for area under the concentration versus time curve of cyclosporin A using several routine monitoring results in renal transplant patients.
    Shibata N; Hayakawa T; Hoshino N; Minouchi T; Yamaji A
    Biol Pharm Bull; 1997 Aug; 20(8):897-903. PubMed ID: 9300138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sampling strategy to calculate the cyclosporin-A area under the time-concentration curve.
    David-Neto E; Araujo LM; Brito ZM; Alves CF; Lemos FC; Yagyu EM; Nahas WC; Ianhez LE
    Am J Transplant; 2002 Jul; 2(6):546-50. PubMed ID: 12118899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of AUC(0-4) predictive methods for cyclosporine in kidney transplant patients].
    Aoyama T; Matsumoto Y; Shimizu M; Fukuoka M; Kimura T; Kokubun H; Yoshida K; Yago K
    Yakugaku Zasshi; 2005 May; 125(5):441-7. PubMed ID: 15863976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.